Lisa Gill
Stock Analyst at JP Morgan
(2.13)
# 1,538
Out of 4,667 analysts
122
Total ratings
39.58%
Success rate
-3.91%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Reinstates: Overweight | $40 | $17.25 | +131.88% | 1 | Nov 6, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Overweight | $20 → $15 | $8.24 | +82.04% | 14 | Aug 30, 2024 | |
| TDOC Teladoc Health | Maintains: Neutral | $16 → $9 | $9.00 | - | 9 | Aug 26, 2024 | |
| OMI Owens & Minor | Maintains: Underweight | $22 → $18 | $11.89 | +51.39% | 4 | Aug 21, 2024 | |
| MCK McKesson | Maintains: Overweight | $656 → $661 | $621.14 | +6.42% | 13 | Aug 21, 2024 | |
| HUM Humana | Maintains: Neutral | $332 → $396 | $293.97 | +34.71% | 5 | Aug 21, 2024 | |
| CI The Cigna Group | Maintains: Overweight | $435 → $438 | $323.39 | +35.44% | 13 | Aug 21, 2024 | |
| COR Cencora | Maintains: Overweight | $280 → $287 | $243.20 | +18.01% | 1 | Aug 21, 2024 | |
| CAH Cardinal Health | Maintains: Neutral | $111 → $123 | $120.34 | +2.21% | 4 | Aug 21, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Overweight | $29 | $21.26 | +36.41% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $16.44 | +9.49% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $294.64 | +34.06% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $237.85 | +2.17% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $101 → $86 | $56.83 | +51.33% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $197.52 | -5.83% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $546 → $559 | $600.50 | -6.91% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $151.84 | -7.80% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $152 → $155 | $161.32 | -3.92% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $333.00 | -0.30% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $397.48 | +58.75% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.70 | +27.66% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $38 → $30 | $20.79 | +44.30% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.31 | +132.02% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $1.67 | +438.92% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $5.77 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.22 | +10.80% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $46 → $44 | $21.88 | +101.10% | 2 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $73.73 | +12.57% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $10 | $11.95 | -16.32% | 3 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $45 → $40 | $22.51 | +77.70% | 3 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $59.10 | +65.82% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $24 | $20.06 | +19.64% | 4 | Jun 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $22.23 | - | 4 | Dec 19, 2017 |
PACS Group
Nov 6, 2024
Reinstates: Overweight
Price Target: $40
Current: $17.25
Upside: +131.88%
Walgreens Boots Alliance
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $8.24
Upside: +82.04%
Teladoc Health
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $9.00
Upside: -
Owens & Minor
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $11.89
Upside: +51.39%
McKesson
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $621.14
Upside: +6.42%
Humana
Aug 21, 2024
Maintains: Neutral
Price Target: $332 → $396
Current: $293.97
Upside: +34.71%
The Cigna Group
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $323.39
Upside: +35.44%
Cencora
Aug 21, 2024
Maintains: Overweight
Price Target: $280 → $287
Current: $243.20
Upside: +18.01%
Cardinal Health
Aug 21, 2024
Maintains: Neutral
Price Target: $111 → $123
Current: $120.34
Upside: +2.21%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Overweight
Price Target: $29
Current: $21.26
Upside: +36.41%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $16.44
Upside: +9.49%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $294.64
Upside: +34.06%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $237.85
Upside: +2.17%
May 30, 2024
Maintains: Overweight
Price Target: $101 → $86
Current: $56.83
Upside: +51.33%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $197.52
Upside: -5.83%
May 30, 2024
Maintains: Overweight
Price Target: $546 → $559
Current: $600.50
Upside: -6.91%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $151.84
Upside: -7.80%
May 30, 2024
Maintains: Neutral
Price Target: $152 → $155
Current: $161.32
Upside: -3.92%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $333.00
Upside: -0.30%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $397.48
Upside: +58.75%
Mar 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $4.70
Upside: +27.66%
Mar 6, 2024
Maintains: Overweight
Price Target: $38 → $30
Current: $20.79
Upside: +44.30%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.31
Upside: +132.02%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $1.67
Upside: +438.92%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $5.77
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.22
Upside: +10.80%
Oct 18, 2023
Maintains: Overweight
Price Target: $46 → $44
Current: $21.88
Upside: +101.10%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $73.73
Upside: +12.57%
Jul 7, 2023
Maintains: Neutral
Price Target: $12 → $10
Current: $11.95
Upside: -16.32%
Mar 2, 2023
Maintains: Neutral
Price Target: $45 → $40
Current: $22.51
Upside: +77.70%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $59.10
Upside: +65.82%
Jun 7, 2018
Maintains: Underweight
Price Target: $26 → $24
Current: $20.06
Upside: +19.64%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $22.23
Upside: -